alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › transient

transient

3 studies tagged transient, dated 2001-01-01 to 2025-08-21. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Amyloid Clearance and Transient CSF Aβ40 Reduction in a Case of ARIA-E/H Following Lecanemab Treatment 2025-08-21
  2. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat 2016-01-01
  3. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke 2001-01-01

Studies

3 studies carry this tag.

Date range

2001 to 2025

Top journals

  • Internal medicine (Tokyo, Japan) 1
  • Neuroreport 1
  • Neuroscience letters 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Amyloid Clearance and Transient CSF Aβ40 Reduction in a Case of ARIA-E/H Following Lecanemab Treatment

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Internal medicine (Tokyo, Japan) 2025-08-21 Treatments

    We herein report a case of amyloid-related imaging abnormalities (ARIA)-E/H following lecanemab treatment in a 70-year-old man with mild cognitive impairment due to Alzheimer's disease.

  2. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroreport 2016-01-01 Drug development

    Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have been shown to be neuroprotective in previous studies in animal models of Alzheimer's or Parkinson's disease.

  3. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Neuroscience letters 2001-01-01 Tau biomarkers

    An increase in cerebrospinal fluid (CSF)-total-tau, and recently also in CSF-phospho-tau, has been found in Alzheimer's disease (AD).

All topic tags with their study counts